Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

John C. Byrd, Wojciech Jurczak, Susan O’Brien et al.|Journal of Clinical Oncology|2021

Cited by 630